Approvals/TGA/DARZALEX daratumumab 400 mg/20 mL concentrated solution for infusion vial

Approved

STANDARD

DARZALEX daratumumab 400 mg/20 mL concentrated solution for infusion vial

Janssen-Cilag Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f0cd2c2ba30fa19a
Product Name: DARZALEX daratumumab 400 mg/20 mL concentrated solution for infusion vial
Artg Id: 281843
Artg Name: DARZALEX daratumumab 400 mg/20 mL concentrated solution for infusion vial
Sponsor: Janssen-Cilag Pty Ltd
Company Detail Path: /organization/janssen-cilag-pty-ltd
Artg Date: 2017-07-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/2c82183fed833de62f3cb6a92f279154.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/d6af7f3168544a3ca07d31fd1fc15ded.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

f0cd2c2ba30fa19a

Type

Standard